Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Previous issues

Page Path
HOME > Browse > Previous issues
13 Previous issues
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 41(5); October 2017
Prev issue Next issue
Reviews
Obesity and Metabolic Syndrome
Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism
Muthu Periasamy, Jose Luis Herrera, Felipe C. G. Reis
Diabetes Metab J. 2017;41(5):327-336.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.327
  • 8,861 View
  • 207 Download
  • 110 Web of Science
  • 115 Crossref
AbstractAbstract PDFPubReader   

Obesity and diabetes has become a major epidemic across the globe. Controlling obesity has been a challenge since this would require either increased physical activity or reduced caloric intake; both are difficult to enforce. There has been renewed interest in exploiting pathways such as uncoupling protein 1 (UCP1)-mediated uncoupling in brown adipose tissue (BAT) and white adipose tissue to increase energy expenditure to control weight gain. However, relying on UCP1-based thermogenesis alone may not be sufficient to control obesity in humans. On the other hand, skeletal muscle is the largest organ and a major contributor to basal metabolic rate and increasing energy expenditure in muscle through nonshivering thermogenic mechanisms, which can substantially affect whole body metabolism and weight gain. In this review we will describe the role of Sarcolipin-mediated uncoupling of Sarcoplasmic Reticulum Calcium ATPase (SERCA) as a potential mechanism for increased energy expenditure both during cold and diet-induced thermogenesis.

Citations

Citations to this article as recorded by  
  • Nutrition as the foundation for successful aging: a focus on dietary protein and omega-3 polyunsaturated fatty acids
    Aubree L Hawley, Jamie I Baum
    Nutrition Reviews.2024; 82(3): 389.     CrossRef
  • Seasonal adaptation of Mangalica pigs in terms of muscle morphology and metabolism
    Sangwoo Kim, Chisato Nakayama, Daisuke Kondoh, Tatsuki Okazaki, Erina Yoneda, Kisaki Tomita, Motoki Sasaki, Yuki Muranishi
    Anatomia, Histologia, Embryologia.2024;[Epub]     CrossRef
  • In vivo heat production dynamics during a contraction-relaxation cycle in rat single skeletal muscle fibers
    Ayaka Tabuchi, Yoshinori Tanaka, Hiroshi Horikawa, Takuto Tazawa, David C. Poole, Yutaka Kano
    Journal of Thermal Biology.2024; 119: 103760.     CrossRef
  • Echinacoside stimulates myogenesis and ATP-dependent thermogenesis in the skeletal muscle via the activation of D1-like dopaminergic receptors
    Kiros Haddish, Jong Won Yun
    Archives of Biochemistry and Biophysics.2024; 752: 109886.     CrossRef
  • Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology
    Sevgi Döndü Özen, Serkan Kir
    Trends in Molecular Medicine.2024;[Epub]     CrossRef
  • Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats
    D. Salagre, M. Navarro-Alarcón, M. Villalón-Mir, B. Alcázar-Navarrete, G. Gómez-Moreno, F. Tamimi, A. Agil
    Biomedicine & Pharmacotherapy.2024; 172: 116314.     CrossRef
  • The effect of high fat diet and endurance training on newly discovery of nonshivering-thermogenic factors under thermoneutrality in mice
    S. Daneshyar, A. Ghasemnian, Z. Mirakhori, S.J. Daneshyar
    Science & Sports.2023; 38(3): 293.     CrossRef
  • Redox‐metabolic reprogramming of skin in mice lacking functional Nrf2 under basal conditions and cold acclimation
    Tamara Zakic, Sara Stojanovic, Aleksandra Jankovic, Aleksandra Korac, Vanja Pekovic‐Vaughan, Bato Korac
    BioFactors.2023; 49(3): 600.     CrossRef
  • Rats lackingUcp1present a novel translational tool for the investigation of thermogenic adaptation during cold challenge
    Jaycob D. Warfel, Carrie M. Elks, David S. Bayless, Bolormaa Vandanmagsar, Allison C. Stone, Samuel E. Velasquez, Paola Olivares‐Nazar, Robert C. Noland, Sujoy Ghosh, Jingying Zhang, Randall L. Mynatt
    Acta Physiologica.2023;[Epub]     CrossRef
  • SENP2 knockdown in human adipocytes reduces glucose metabolism and lipid accumulation, while increases lipid oxidation
    Solveig A. Krapf, Jenny Lund, Hege G. Bakke, Tuula A. Nyman, Stefano Bartesaghi, Xiao-Rong Peng, Arild C. Rustan, G. Hege Thoresen, Eili T. Kase
    Metabolism Open.2023; 18: 100234.     CrossRef
  • Physiological and molecular mechanisms of cold-induced improvements in glucose homeostasis in humans beyond brown adipose tissue
    Sten van Beek, Dzhansel Hashim, Tore Bengtsson, Joris Hoeks
    International Journal of Obesity.2023; 47(5): 338.     CrossRef
  • Distinct Transcriptional Responses of Skeletal Muscle to Short-Term Cold Exposure in Tibetan Pigs and Bama Pigs
    Chunhuai Yang, Chunwei Cao, Jiali Liu, Ying Zhao, Jianfei Pan, Cong Tao, Yanfang Wang
    International Journal of Molecular Sciences.2023; 24(8): 7431.     CrossRef
  • Distinct and shared endothermic strategies in the heat producing tissues of tuna and other teleosts
    Baosheng Wu, Xueli Gao, Mingling Hu, Jing Hu, Tianming Lan, Tingfeng Xue, Wenjie Xu, Chenglong Zhu, Yuan Yuan, Jiangmin Zheng, Tao Qin, Peidong Xin, Ye Li, Li Gong, Chenguang Feng, Shunping He, Huan Liu, Haimeng Li, Qing Wang, Zhenhua Ma, Qiang Qiu, Kun W
    Science China Life Sciences.2023; 66(11): 2629.     CrossRef
  • Macrophage Involvement in Aging-Associated Skeletal Muscle Regeneration
    Chang-Yi Cui, Luigi Ferrucci, Myriam Gorospe
    Cells.2023; 12(9): 1214.     CrossRef
  • Anti-nucleolin aptamer, iSN04, inhibits the inflammatory responses in C2C12 myoblasts by modulating the β-catenin/NF-κB signaling pathway
    Machi Yamamoto, Mana Miyoshi, Kamino Morioka, Takakazu Mitani, Tomohide Takaya
    Biochemical and Biophysical Research Communications.2023; 664: 1.     CrossRef
  • Building Cetacean Locomotor Muscles throughout Ontogeny to Support High-Performance Swimming into Adulthood
    S R Noren
    Integrative And Comparative Biology.2023; 63(3): 785.     CrossRef
  • Filbertone, (2E)-5-methyl-2-hepten-4-one, regulates thermogenesis and lipid metabolism in skeletal muscle of a high-fat diet fed mice
    Hyemee Kim, Byungyong Ahn
    Applied Biological Chemistry.2023;[Epub]     CrossRef
  • Silencing of dopamine receptor D5 inhibits the browning of 3T3-L1 adipocytes and ATP-consuming futile cycles in C2C12 muscle cells
    Kiros Haddish, Jong Won Yun
    Archives of Physiology and Biochemistry.2023; : 1.     CrossRef
  • Dynamic of irisin secretion change after moderate-intensity chronic physical exercise on obese female
    Desiana Merawati, Sugiharto, Hendra Susanto, Ahmad Taufiq, Adi Pranoto, Dessy Amelia, Purwo Sri Rejeki
    Journal of Basic and Clinical Physiology and Pharmacology.2023; 34(4): 539.     CrossRef
  • Polyamines and Physical Activity in Musculoskeletal Diseases: A Potential Therapeutic Challenge
    Letizia Galasso, Annalisa Cappella, Antonino Mulè, Lucia Castelli, Andrea Ciorciari, Alessandra Stacchiotti, Angela Montaruli
    International Journal of Molecular Sciences.2023; 24(12): 9798.     CrossRef
  • Phosphate toxicity and SERCA2a dysfunction in sudden cardiac arrest
    Ronald B. Brown
    The FASEB Journal.2023;[Epub]     CrossRef
  • Hepatic protein kinase Cbeta deficiency mitigates late-onset obesity
    Yaoling Shu, Nikhil Gumma, Faizule Hassan, Daniel A. Branch, Lisa A. Baer, Michael C. Ostrowski, Kristin I. Stanford, Kedryn K. Baskin, Kamal D. Mehta
    Journal of Biological Chemistry.2023; 299(8): 104917.     CrossRef
  • Functional expression of the thermally activated transient receptor potential channels TRPA1 and TRPM8 in human myotubes
    Christine Skagen, Nils Gunnar Løvsletten, Lucia Asoawe, Zeineb Al-Karbawi, Arild C. Rustan, G. Hege Thoresen, Fred Haugen
    Journal of Thermal Biology.2023; 116: 103623.     CrossRef
  • Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management
    Ummul Fathima Shaik Mohamed Sayed, Said Moshawih, Hui Poh Goh, Nurolaini Kifli, Gaurav Gupta, Sachin Kumar Singh, Dinesh Kumar Chellappan, Kamal Dua, Andi Hermansyah, Hooi Leng Ser, Long Chiau Ming, Bey Hing Goh
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Recent advancements in pharmacological strategies to modulate energy balance for combating obesity
    Benudhara Pati, Satyabrata Sendh, Bijayashree Sahu, Sunil Pani, Nivedita Jena, Naresh Chandra Bal
    RSC Medicinal Chemistry.2023; 14(8): 1429.     CrossRef
  • CCE and EODF as two distinct non-shivering thermogenesis models inducing weight loss
    Tianyi Xu, Juan Wang, Hongwei Shi, Xiaofang Wei, Huiling Zhang, Yunyan Ji, Shiting Lu, Yi Yan, Xiuju Yu, Xiaomao Luo, Haidong Wang
    Pflügers Archiv - European Journal of Physiology.2023; 475(8): 961.     CrossRef
  • Birth and the Pathway to Adulthood: Integration across Development, Environment, and Evolution
    Christopher J Mayerl, Terry R Dial, Mark C Mainwaring, Ashley M Heers, Rebecca Z German
    Integrative And Comparative Biology.2023; 63(3): 548.     CrossRef
  • Adipose Tissue and Metabolic Health
    Sung-Min An, Seung-Hee Cho, John C. Yoon
    Diabetes & Metabolism Journal.2023; 47(5): 595.     CrossRef
  • The RANK-RANK-L-OPG pathway: trait d’union between bone and muscle
    Giovanni Iolascon, Sara Liguori, Marco Paoletta, Federica Tomaino, Antimo Moretti
    International Journal of Bone Fragility.2023; 3(2): 56.     CrossRef
  • Warm Cells, Hot Mitochondria: Achievements and Problems of Ultralocal Thermometry
    Alexey G. Kruglov, Alexey M. Romshin, Anna B. Nikiforova, Arina Plotnikova, Igor I. Vlasov
    International Journal of Molecular Sciences.2023; 24(23): 16955.     CrossRef
  • Plant extracts in prevention of obesity
    Han-Ning Wang, Jin-Zhu Xiang, Zhi Qi, Min Du
    Critical Reviews in Food Science and Nutrition.2022; 62(8): 2221.     CrossRef
  • Transcription factor EB enhances autophagy and ameliorates palmitate‐induced insulin resistance at least partly via upregulating AMPK activity in skeletal muscle cells
    Ping Wang, Chun Guang Li, Xian Zhou, Shuzhe Ding
    Clinical and Experimental Pharmacology and Physiology.2022; 49(2): 302.     CrossRef
  • ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity
    Alexandra J. Brownstein, Michaela Veliova, Rebeca Acin-Perez, Marc Liesa, Orian S. Shirihai
    Reviews in Endocrine and Metabolic Disorders.2022; 23(1): 121.     CrossRef
  • Skeletal muscle plasticity and thermogenesis: Insights from sea otters
    Traver Wright, Melinda Sheffield-Moore
    Temperature.2022; 9(2): 119.     CrossRef
  • Augmented CCL5/CCR5 signaling in brown adipose tissue inhibits adaptive thermogenesis and worsens insulin resistance in obesity
    Pei-Chi Chan, Li-Man Hung, Jiung-Pang Huang, Yuan-Ji Day, Chao-Lan Yu, Feng-Chih Kuo, Chieh-Hua Lu, Yu-Feng Tian, Po-Shiuan Hsieh
    Clinical Science.2022; 136(1): 121.     CrossRef
  • Altered muscle mitochondrial, inflammatory and trophic markers, and reduced exercise training adaptations in type 1 diabetes
    Dean Minnock, Giosuè Annibalini, Giacomo Valli, Roberta Saltarelli, Mauricio Krause, Elena Barbieri, Giuseppe De Vito
    The Journal of Physiology.2022; 600(6): 1405.     CrossRef
  • Maternal exercise intergenerationally drives muscle-based thermogenesis via activation of apelin-AMPK signaling
    Jun Seok Son, Song Ah Chae, Liang Zhao, Hongyang Wang, Jeanene M. de Avila, Mei-Jun Zhu, Zhihua Jiang, Min Du
    eBioMedicine.2022; 76: 103842.     CrossRef
  • Ca 2+ leak through ryanodine receptor 1 regulates thermogenesis in resting skeletal muscle
    Aldo Meizoso-Huesca, Luke Pearce, Christopher J. Barclay, Bradley S. Launikonis
    Proceedings of the National Academy of Sciences.2022;[Epub]     CrossRef
  • Deep transcranial magnetic stimulation in combination with skin thermography in obesity: a window on sympathetic nervous system
    Anna Ferrulli, Sara Gandini, Giulio Cammarata, Veronica Redaelli, Stefano Massarini, Concetta Macrì, Ileana Terruzzi, Daniele Cannavaro, Fabio Luzi, Livio Luzi
    Acta Diabetologica.2022; 59(5): 729.     CrossRef
  • Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
    Abel M. Mengeste, Parmeshwar Katare, Andrea Dalmao Fernandez, Jenny Lund, Hege G. Bakke, David Baker, Stefano Bartesaghi, Xiao-Rong Peng, Arild C. Rustan, G. Hege Thoresen, Eili Tranheim Kase
    Molecular Biology Reports.2022; 49(7): 6005.     CrossRef
  • The Role of Thyroid Hormones on Skeletal Muscle Thermogenesis
    Nadia Sawicka-Gutaj, Abikasinee Erampamoorthy, Ariadna Zybek-Kocik, Angelos Kyriacou, Małgorzata Zgorzalewicz-Stachowiak, Agata Czarnywojtek, Marek Ruchała
    Metabolites.2022; 12(4): 336.     CrossRef
  • SS‐31 does not prevent or reduce muscle atrophy 7 days after a 65 kdyne contusion spinal cord injury in young male mice
    Zachary A. Graham, Jennifer J. DeBerry, Christopher P. Cardozo, Marcas M. Bamman
    Physiological Reports.2022;[Epub]     CrossRef
  • Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c)
    Tae Kwan Yoon, Chan Hee Lee, Obin Kwon, Min-Seon Kim
    Diabetes & Metabolism Journal.2022; 46(3): 402.     CrossRef
  • Insight Into the Metabolic Adaptations of Electrically Pulse-Stimulated Human Myotubes Using Global Analysis of the Transcriptome and Proteome
    Abel M. Mengeste, Nataša Nikolić, Andrea Dalmao Fernandez, Yuan Z. Feng, Tuula A. Nyman, Sander Kersten, Fred Haugen, Eili Tranheim Kase, Vigdis Aas, Arild C. Rustan, G. Hege Thoresen
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • The Role of Thermogenic Fat Tissue in Energy Consumption
    Masato Horino, Kenji Ikeda, Tetsuya Yamada
    Current Issues in Molecular Biology.2022; 44(7): 3166.     CrossRef
  • Investigation of obesogenic effects of hexachlorobenzene, DDT and DDE in male rats
    Zeyad Ayad Fadhil Al-Obaidi, Cihan Süleyman Erdogan, Engin Sümer, Hüseyin Bugra Özgün, Burcu Gemici, Süleyman Sandal, Bayram Yilmaz
    General and Comparative Endocrinology.2022; 327: 114098.     CrossRef
  • Avian adjustments to cold and non‐shivering thermogenesis: whats, wheres and hows
    Punyadhara Pani, Naresh C. Bal
    Biological Reviews.2022; 97(6): 2106.     CrossRef
  • Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
    Harold Edward Bays, Angela Golden, Justin Tondt
    Obesity Pillars.2022; 3: 100034.     CrossRef
  • Myogenetic Oligodeoxynucleotide Restores Differentiation and Reverses Inflammation of Myoblasts Aggravated by Cancer-Conditioned Medium
    Yuma Nihashi, Machi Yamamoto, Takeshi Shimosato, Tomohide Takaya
    Muscles.2022; 1(2): 111.     CrossRef
  • Altered skeletal muscle sarco-endoplasmic reticulum Ca2+-ATPase calcium transport efficiency after a thermogenic stimulus
    Lydia A. Heemstra, Lauren G. Koch, Steven L. Britton, Colleen M. Novak
    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2022; 323(5): R628.     CrossRef
  • Animal Welfare Compromises Associated with Causes of Death in Neonatal Piglets
    Kirsty L. Chidgey, Nutnapong Udomteerasuwat, Patrick C. H. Morel, Fernanda Castillo-Alcala
    Animals.2022; 12(21): 2933.     CrossRef
  • Brown to White Fat Transition Overlap With Skeletal Muscle During Development of Larger Mammals: Is it a Coincidence?
    Sunil Pani, Suchanda Dey, Benudhara Pati, Unmod Senapati, Naresh C Bal
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • Anti‐adiposity and lipid‐lowering effects of schisandrol A in diet‐induced obese mice
    Sang Ryong Kim, Hyo Jin Park, Un Ju Jung
    Journal of Food Biochemistry.2022;[Epub]     CrossRef
  • Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
    Haruki Wakai, Natsumi Abe, Touno Tokuda, Rika Yamanaka, Satoshi Ebihara, Kensuke Izumaru, Daisuke Ishii, Toru Hyodo, Kazunari Yoshida
    BMC Infectious Diseases.2022;[Epub]     CrossRef
  • Organotypic cultures as aging associated disease models
    Martina M. Sanchez, Isabella A. Bagdasarian, William Darch, Joshua T. Morgan
    Aging.2022; 14(22): 9338.     CrossRef
  • Divergent remodeling of the skeletal muscle metabolome over 24 h between young, healthy men and older, metabolically compromised men
    Jan-Frieder Harmsen, Michel van Weeghel, Rex Parsons, Georges E. Janssens, Jakob Wefers, Dirk van Moorsel, Jan Hansen, Joris Hoeks, Matthijs K.C. Hesselink, Riekelt H. Houtkooper, Patrick Schrauwen
    Cell Reports.2022; 41(11): 111786.     CrossRef
  • Structural functionality of skeletal muscle mitochondria and its correlation with metabolic diseases
    Gourabamani Swalsingh, Punyadhara Pani, Naresh C. Bal
    Clinical Science.2022; 136(24): 1851.     CrossRef
  • Trans-anethole Induces Thermogenesis via Activating SERCA/SLN Axis in C2C12 Muscle Cells
    Sulagna Mukherjee, Minji Choi, Jong Won Yun
    Biotechnology and Bioprocess Engineering.2022; 27(6): 938.     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Nutmeg extract potentially alters characteristics of white adipose tissue in rats
    Ronny Lesmana, Melisa Siannoto, Gaga I. Nugraha, Hanna Goenawan, Astrid K. Feinisa, Yuni S. Pratiwi, Fifi Veronica, Vita M. Tarawan, Susianti Susianti, Unang Supratman
    Veterinary Medicine and Science.2021; 7(2): 512.     CrossRef
  • Contribution of thermogenic mechanisms by male and female mice lacking pituitary adenylate cyclase-activating polypeptide in response to cold acclimation
    Ekaterina Filatov, Landon I. Short, Maeghan A. M. Forster, Simon S. Harris, Erik N. Schien, Malcolm C. Hughes, Daemon L. Cline, Colin J. Appleby, Sarah L. Gray
    American Journal of Physiology-Endocrinology and Metabolism.2021; 320(3): E475.     CrossRef
  • Skeletal muscle non-shivering thermogenesis as an attractive strategy to combat obesity
    Hanbing Li, Can Wang, Linghuan Li, Lingqiao Li
    Life Sciences.2021; 269: 119024.     CrossRef
  • Restriction of an intron size en route to endothermy
    Jana Královičová, Ivana Borovská, Reuben Pengelly, Eunice Lee, Pavel Abaffy, Radek Šindelka, Frank Grutzner, Igor Vořechovský
    Nucleic Acids Research.2021; 49(5): 2460.     CrossRef
  • Skeletal muscle specific mitochondrial dysfunction and altered energy metabolism in a murine model (oim/oim) of severe osteogenesis imperfecta
    Victoria L. Gremminger, Emily N. Harrelson, Tara K. Crawford, Adrienne Ohler, Laura C. Schulz, R. Scott Rector, Charlotte L. Phillips
    Molecular Genetics and Metabolism.2021; 132(4): 244.     CrossRef
  • Body Protein Sparing in Hibernators: A Source for Biomedical Innovation
    Fabrice Bertile, Caroline Habold, Yvon Le Maho, Sylvain Giroud
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • The Genomes of Two Billfishes Provide Insights into the Evolution of Endothermy in Teleosts
    Baosheng Wu, Chenguang Feng, Chenglong Zhu, Wenjie Xu, Yuan Yuan, Mingliang Hu, Ke Yuan, Yongxin Li, Yandong Ren, Yang Zhou, Haifeng Jiang, Qiang Qiu, Wen Wang, Shunping He, Kun Wang, Guang Yang
    Molecular Biology and Evolution.2021; 38(6): 2413.     CrossRef
  • Is Upregulation of Sarcolipin Beneficial or Detrimental to Muscle Function?
    Naresh C. Bal, Subash C. Gupta, Meghna Pant, Danesh H. Sopariwala, Geoffrey Gonzalez-Escobedo, Joanne Turner, John S. Gunn, Christopher R. Pierson, Scott Q. Harper, Jill A. Rafael-Fortney, Muthu Periasamy
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Real‐Time Assessment of Mitochondrial Toxicity in HepG2 Cells Using the Seahorse Extracellular Flux Analyzer
    Jether Amos Espinosa, Grace Pohan, Michelle R. Arkin, Sarine Markossian
    Current Protocols.2021;[Epub]     CrossRef
  • Effects of Ecklonia stolonifera extract on the obesity and skeletal muscle regeneration in high-fat diet-fed mice
    Heegu Jin, Hyun-Ji Oh, Junghee Kim, Kang-Pyo Lee, Xionggao Han, Ok-Hwan Lee, Boo-Yong Lee
    Journal of Functional Foods.2021; 82: 104511.     CrossRef
  • The Effect of Dietary Intake and Nutritional Status on Anthropometric Development and Systemic Inflammation: An Observational Study
    Roxana Maria Martin-Hadmaș, Ștefan Adrian Martin, Adela Romonți, Cristina Oana Mărginean
    International Journal of Environmental Research and Public Health.2021; 18(11): 5635.     CrossRef
  • Thermographic imaging of mouse across circadian time reveals body surface temperature elevation associated with non-locomotor body movements
    Hiroyuki Shimatani, Yuichi Inoue, Yota Maekawa, Takahito Miyake, Yoshiaki Yamaguchi, Masao Doi, Nicolas Cermakian
    PLOS ONE.2021; 16(5): e0252447.     CrossRef
  • Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach
    Andreia Gomes, Pedro Coelho, Raquel Soares, Raquel Costa
    Cell and Tissue Research.2021; 385(3): 497.     CrossRef
  • Central vs. Peripheral Action of Thyroid Hormone in Adaptive Thermogenesis: A Burning Topic
    Yanis Zekri, Frédéric Flamant, Karine Gauthier
    Cells.2021; 10(6): 1327.     CrossRef
  • Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
    Shunichi Nakamura, Shinichi Yonekura, Takeshi Shimosato, Tomohide Takaya
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Lipophorin receptor 1 (LpR1) in Drosophila muscle influences life span by regulating mitochondrial aging
    Ae-kyeong Kim, Dae-Woo Kwon, Eunbyul Yeom, Kwang-Pyo Lee, Ki-Sun Kwon, Kweon Yu, Kyu-Sun Lee
    Biochemical and Biophysical Research Communications.2021; 568: 95.     CrossRef
  • Skeletal muscle thermogenesis enables aquatic life in the smallest marine mammal
    Traver Wright, Randall W. Davis, Heidi C. Pearson, Michael Murray, Melinda Sheffield-Moore
    Science.2021; 373(6551): 223.     CrossRef
  • Myoglobin, expressed in brown adipose tissue of mice, regulates the content and activity of mitochondria and lipid droplets
    Mostafa A. Aboouf, Julia Armbruster, Markus Thiersch, Max Gassmann, Axel Gödecke, Erich Gnaiger, Glen Kristiansen, Anne Bicker, Thomas Hankeln, Hao Zhu, Thomas A. Gorr
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2021; 1866(12): 159026.     CrossRef
  • Skeletal muscle energy metabolism in obesity
    Abel M. Mengeste, Arild C. Rustan, Jenny Lund
    Obesity.2021; 29(10): 1582.     CrossRef
  • Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration
    Mei Wan, Elise F. Gray-Gaillard, Jennifer H. Elisseeff
    Bone Research.2021;[Epub]     CrossRef
  • The small molecule SERCA activator CDN1163 increases energy metabolism in human skeletal muscle cells
    Abel M. Mengeste, Jenny Lund, Parmeshwar Katare, Roya Ghobadi, Hege G. Bakke, Per Kristian Lunde, Lars Eide, Gavin O’ Mahony, Sven Göpel, Xiao-Rong Peng, Eili Tranheim Kase, G. Hege Thoresen, Arild C. Rustan
    Current Research in Pharmacology and Drug Discovery.2021; 2: 100060.     CrossRef
  • Antioxidant Properties and Cytoprotective Effect of Pistacia lentiscus L. Seed Oil against 7β-Hydroxycholesterol-Induced Toxicity in C2C12 Myoblasts: Reduction in Oxidative Stress, Mitochondrial and Peroxisomal Dysfunctions and Attenuation of Cell Death
    Imen Ghzaiel, Amira Zarrouk, Thomas Nury, Michela Libergoli, Francesca Florio, Souha Hammouda, Franck Ménétrier, Laure Avoscan, Aline Yammine, Mohammad Samadi, Norbert Latruffe, Stefano Biressi, Débora Levy, Sérgio Paulo Bydlowski, Sonia Hammami, Anne Vej
    Antioxidants.2021; 10(11): 1772.     CrossRef
  • Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions
    Faiz-ul Hassan, Asif Nadeem, Zhipeng Li, Maryam Javed, Qingyou Liu, Jahanzaib Azhar, Muhammad Saif-ur Rehman, Kuiqing Cui, Saif ur Rehman
    International Journal of Molecular Sciences.2021; 22(22): 12463.     CrossRef
  • Differential Effects of 25-Hydroxyvitamin D3 versus 1α 25-Dihydroxyvitamin D3 on Adipose Tissue Browning in CKD-Associated Cachexia
    Robert H. Mak, Uwe Querfeld, Alex Gonzalez, Sujana Gunta, Wai W. Cheung
    Cells.2021; 10(12): 3382.     CrossRef
  • Effects of Starvation on Antioxidant-Related Signaling Molecules, Oxidative Stress, and Autophagy in Juvenile Chinese Perch Skeletal Muscle
    Ping Wu, Aimin Wang, Jia Cheng, Lin Chen, Yaxiong Pan, Honghui Li, Qi Zhang, Jiaqi Zhang, Wuying Chu, Jianshe Zhang
    Marine Biotechnology.2020; 22(1): 81.     CrossRef
  • Thermogenic adipocytes: lineage, function and therapeutic potential
    Alice E. Pollard, David Carling
    Biochemical Journal.2020; 477(11): 2071.     CrossRef
  • Hypoglycaemic effect of catalpol in a mouse model of high-fat diet-induced prediabetes
    Dengqiu Xu, Xiaofei Huang, Hozeifa M. Hassan, Lu Wang, Sijia Li, Zhenzhou Jiang, Luyong Zhang, Tao Wang
    Applied Physiology, Nutrition, and Metabolism.2020; 45(10): 1127.     CrossRef
  • The evolution of mechanisms involved in vertebrate endothermy
    Lucas J. Legendre, Donald Davesne
    Philosophical Transactions of the Royal Society B: Biological Sciences.2020; 375(1793): 20190136.     CrossRef
  • Uncoupling of sarcoendoplasmic reticulum calcium ATPase pump activity by sarcolipin as the basis for muscle non-shivering thermogenesis
    Naresh C. Bal, Muthu Periasamy
    Philosophical Transactions of the Royal Society B: Biological Sciences.2020; 375(1793): 20190135.     CrossRef
  • Prediction of muscle mass in arms and legs based on 3D laser-based photonic body scans’ standard dimensions in a homogenous sample of young men
    Cristine Cavegn, Frank Rühli, Nicole Bender, Kaspar Staub
    Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization.2020; 8(5): 562.     CrossRef
  • Thermogenesis in Adipose Tissue Activated by Thyroid Hormone
    Winifred W. Yau, Paul M. Yen
    International Journal of Molecular Sciences.2020; 21(8): 3020.     CrossRef
  • Interaction of a Sarcolipin Pentamer and Monomer with the Sarcoplasmic Reticulum Calcium Pump, SERCA
    John Paul Glaves, Joseph O. Primeau, Przemek A. Gorski, L. Michel Espinoza-Fonseca, M. Joanne Lemieux, Howard S. Young
    Biophysical Journal.2020; 118(2): 518.     CrossRef
  • Automated CT-derived skeletal muscle mass determination in lower hind limbs of mice using a 3D U-Net deep learning network
    Brent van der Heyden, Wouter R. P. H. van de Worp, Ardy van Helvoort, Jan Theys, Annemie M. W. J. Schols, Ramon C. J. Langen, Frank Verhaegen
    Journal of Applied Physiology.2020; 128(1): 42.     CrossRef
  • Modified creatinine index and risk for long-term infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-Cohort Study
    Hokuto Arase, Shunsuke Yamada, Hiroto Hiyamuta, Masatomo Taniguchi, Masanori Tokumoto, Kazuhiko Tsuruya, Toshiaki Nakano, Takanari Kitazono
    Scientific Reports.2020;[Epub]     CrossRef
  • Ticking for Metabolic Health: The Skeletal‐Muscle Clocks
    Miguel A. Gutierrez‐Monreal, Jan‐Frieder Harmsen, Patrick Schrauwen, Karyn A. Esser
    Obesity.2020;[Epub]     CrossRef
  • Gut microbiota and regulation of myokine-adipokine function
    Francesco Suriano, Matthias Van Hul, Patrice D Cani
    Current Opinion in Pharmacology.2020; 52: 9.     CrossRef
  • P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance
    Roberto Coccurello, Cinzia Volonté
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Primary Active Ca2+ Transport Systems in Health and Disease
    Jialin Chen, Aljona Sitsel, Veronick Benoy, M. Rosario Sepúlveda, Peter Vangheluwe
    Cold Spring Harbor Perspectives in Biology.2020; 12(2): a035113.     CrossRef
  • Sex‐specific alterations in whole body energetics and voluntary activity in heterozygous R163C malignant hyperthermia‐susceptible mice
    Jennifer M. Rutkowsky, Trina A. Knotts, Paul D. Allen, Isaac N. Pessah, Jon J. Ramsey
    The FASEB Journal.2020; 34(6): 8721.     CrossRef
  • The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
    Adrian M. Gonzalez-Gil, Leticia Elizondo-Montemayor
    Nutrients.2020; 12(6): 1899.     CrossRef
  • Emergent Coordination of the CHKB and CPT1B Genes in Eutherian Mammals: Implications for the Origin of Brown Adipose Tissue
    Bhavin V. Patel, Fanrong Yao, Aidan Howenstine, Risa Takenaka, Jacob A. Hyatt, Karen E. Sears, Brian M. Shewchuk
    Journal of Molecular Biology.2020; 432(23): 6127.     CrossRef
  • Chronic cold exposure induces mitochondrial plasticity in deer mice native to high altitudes
    Sajeni Mahalingam, Zachary A. Cheviron, Jay F. Storz, Grant B. McClelland, Graham R. Scott
    The Journal of Physiology.2020; 598(23): 5411.     CrossRef
  • Adaptive thermogenesis enhances the life-threatening response to heat in mice with an Ryr1 mutation
    Hui J. Wang, Chang Seok Lee, Rachel Sue Zhen Yee, Linda Groom, Inbar Friedman, Lyle Babcock, Dimitra K. Georgiou, Jin Hong, Amy D. Hanna, Joseph Recio, Jong Min Choi, Ting Chang, Nadia H. Agha, Jonathan Romero, Poonam Sarkar, Nicol Voermans, M. Waleed Gab
    Nature Communications.2020;[Epub]     CrossRef
  • Sclerostin Influences Exercise-Induced Adaptations in Body Composition and White Adipose Tissue Morphology in Male Mice
    Nigel Kurgan, Joshua Stoikos, Bradley J. Baranowski, Jenalyn Yumol, Roopan Dhaliwal, Jake B. Sweezey-Munroe, Val A. Fajardo, William Gittings, Rebecca E.K. Macpherson, Panagiota Klentrou
    Journal of Bone and Mineral Research.2020; 38(4): 541.     CrossRef
  • Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high‐fat‐diet‐induced pre‐diabetes
    Dengqiu Xu, Zhenzhou Jiang, Zeren Sun, Lu Wang, Guolin Zhao, Hozeifa M. Hassan, Sisi Fan, Wang Zhou, Shuangshuang Han, Luyong Zhang, Tao Wang
    Journal of Cellular Physiology.2019; 234(5): 7510.     CrossRef
  • Noninvasive and in vivo assessment of upper and lower limb skeletal muscle oxidative metabolism activity and microvascular responses to glucose ingestion in humans
    Rogério Nogueira Soares, Alessandro L. Colosio, Juan Manuel Murias, Silvia Pogliaghi
    Applied Physiology, Nutrition, and Metabolism.2019; 44(10): 1105.     CrossRef
  • Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization
    Xiaofang Chen, Shu Zhuo, Tengfei Zhu, Pengle Yao, Mengmei Yang, Hong Mei, Na Li, Fengguang Ma, Ji Ming Wang, Shiting Chen, Richard D. Ye, Yu Li, Yingying Le
    Diabetes.2019; 68(6): 1130.     CrossRef
  • Taurine protects against arsenic trioxide-induced insulin resistance via ROS-Autophagy pathway in skeletal muscle
    Lei Yang, Tianming Qiu, Xiaofeng Yao, Liping Jiang, Sen Wei, Pei Pei, Zhidong Wang, Jie Bai, Xiaofang Liu, Guang Yang, Shuang Liu, Xiance Sun
    The International Journal of Biochemistry & Cell Biology.2019; 112: 50.     CrossRef
  • Increased triacylglycerol - Fatty acid substrate cycling in human skeletal muscle cells exposed to eicosapentaenoic acid
    Nils G. Løvsletten, Siril S. Bakke, Eili T. Kase, D. Margriet Ouwens, G. Hege Thoresen, Arild C. Rustan, Juan J. Loor
    PLOS ONE.2018; 13(11): e0208048.     CrossRef
  • Transient receptor potential (TRP) channels: a metabolic TR(i)P to obesity prevention and therapy
    M. Bishnoi, P. Khare, L. Brown, S. K. Panchal
    Obesity Reviews.2018; 19(9): 1269.     CrossRef
  • Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
    Shreekrishna Lamichane, Babita Dahal Lamichane, Sang-Mo Kwon
    International Journal of Molecular Sciences.2018; 19(4): 949.     CrossRef
  • Antiobesity Effect ofAstilbe chinensisFranch. et Savet. Extract through Regulation of Adipogenesis and AMP-Activated Protein Kinase Pathways in 3T3-L1 Adipocyte and High-Fat Diet-Induced C57BL/6N Obese Mice
    Xian Hua Zhang, Zhiqiang Wang, Bueom-Goo Kang, Seung Hwan Hwang, Jae-Young Lee, Soon Sung Lim, Bo Huang
    Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1.     CrossRef
  • Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation
    Giacomo Giacovazzo, Savina Apolloni, Roberto Coccurello
    Purinergic Signalling.2018; 14(3): 299.     CrossRef
  • Chromatin and Metabolism
    Tamaki Suganuma, Jerry L. Workman
    Annual Review of Biochemistry.2018; 87(1): 27.     CrossRef
  • Zebrafish as a Model for Obesity and Diabetes
    Liqing Zang, Lisette A. Maddison, Wenbiao Chen
    Frontiers in Cell and Developmental Biology.2018;[Epub]     CrossRef
  • Comparison between Dual-Energy X-ray Absorptiometry and Bioelectrical Impedance Analyses for Accuracy in Measuring Whole Body Muscle Mass and Appendicular Skeletal Muscle Mass
    Seo Lee, Soyeon Ahn, Young Kim, Myoung Ji, Kyoung Kim, Sung Choi, Hak Jang, Soo Lim
    Nutrients.2018; 10(6): 738.     CrossRef
Clinical Diabetes & Therapeutics
Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
Diabetes Metab J. 2017;41(5):337-348.   Published online October 17, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.337
  • 7,110 View
  • 64 Download
  • 38 Web of Science
  • 45 Crossref
AbstractAbstract PDFPubReader   

In 2017, the Korean Diabetes Association (KDA) published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the last update in 2015, many results from clinical trials have been introduced, and domestic data from studies performed in Korean patients with T2DM have been published. Recently, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations. Additionally, new data from clinical trials using dipeptidyl peptidase 4 inhibitors and thiazolidinediones in Korean patients with T2DM were added. Following a systematic review and assessment of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the use of antihyperglycemic agents and revised the treatment algorithm for Korean adult patients with T2DM.

Citations

Citations to this article as recorded by  
  • Comparative Study on Efficacy of Empagliflozin Versus Sitagliptin, as an Add-on Therapy to Metformin in Type 2 Diabetic Patients
    Harsh Salankar, Sonali Rode, C. Arjun, Rajeeta Joseph, Gourav B. Deshmane, Radhika P. Vijayan
    Journal of Pharmacy and Bioallied Sciences.2024; 16(Suppl 1): S335.     CrossRef
  • Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients
    Young-Hwan Park, Minji Sohn, So Yeon Lee, Soo Lim
    Diabetes & Metabolism Journal.2024; 48(2): 253.     CrossRef
  • Association of preoperative blood glucose level with delirium after non-cardiac surgery in diabetic patients
    Soo Jung Park, Ah Ran Oh, Jong-Hwan Lee, Kwangmo Yang, Jungchan Park
    Korean Journal of Anesthesiology.2024; 77(2): 226.     CrossRef
  • Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
    R. Pelluri, S. Kongara, V. R. Nagasubramanian, S. Mahadevan, J. Chimakurthy
    Journal of Endocrinological Investigation.2023; 46(5): 855.     CrossRef
  • Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study
    Hyeong Kyu Park, Kyoung‐Ah Kim, Kyung‐Wan Min, Tae‐Seo Sohn, In Kyung Jeong, Chul Woo Ahn, Nan‐Hee Kim, Ie Byung Park, Ho Chan Cho, Choon Hee Chung, Sung Hee Choi, Kang Seo Park, Seoung‐Oh Yang, Kwan Woo Lee
    Diabetes, Obesity and Metabolism.2023; 25(9): 2743.     CrossRef
  • Paradigm Shift in Management of Hyperglycemia in Patients with Type 2 Diabetes: Glucocentric versus Organ Protection
    Jong Chul Won
    The Journal of Korean Diabetes.2023; 24(2): 59.     CrossRef
  • A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation
    Mazhar Ahmed, Asjad Saeed, Muhammad Zarar Khan, Sana Z Javaid, Farhan Aslam, Savida Ilyas Dar
    Cureus.2023;[Epub]     CrossRef
  • Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extensio
    Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2023; 47(6): 808.     CrossRef
  • Efficacy and Safety of Mulberry Twig Alkaloids Tablet for Treatment of Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study
    Ling Qu, Xiao-chun Liang, Guo-qing Tian, Gai-li Zhang, Qun-li Wu, Xiu-mei Huang, Ya-zhong Cui, Yu-ling Liu, Zhu-fang Shen, Guo-qing Ma, Hao Lu, Yi Li, Hong Jiang, Xi-yan Yang, Guang-de Zhang, Chen-hua Yang
    Chinese Journal of Integrative Medicine.2022; 28(4): 304.     CrossRef
  • Risk for Imbalanced Blood Glucose Pattern: Construct Analysis and Nursing Diagnosis Proposal
    Rafael Oliveira Pitta Lopes, Jéssica de Castro Santos, Hudson Carmo de Oliveira, Juliana Faria Campos, Cândida Caniçali Primo, Camila Takáo Lopes, Marcos Antônio Gomes Brandão
    Clinical Nursing Research.2022; 31(7): 1241.     CrossRef
  • Long‐term clinical outcomes of oral antidiabetic drugs as fixed‐dose combinations: A nationwide retrospective cohort study
    Sang‐Jun Cho, In‐Sun Oh, Han Eol Jeong, Young Min Cho, Yul Hwangbo, Oriana Hoi Yun Yu, Ju‐Young Shin
    Diabetes, Obesity and Metabolism.2022; 24(10): 2051.     CrossRef
  • Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
    Muaz Mubashir, Mazhar Ahmed, Hassan Atique, Ahmed Wassan, Mehdi Naqvi, Muneeb Ullah
    Cureus.2022;[Epub]     CrossRef
  • The Mediating Effect of Acceptance Action in the Relationship between Diabetes Distress and Self-stigma among Old Adults with Diabetes in South Korea
    Hyesun Kim, Kawoun Seo
    Journal of Korean Academy of Community Health Nursing.2022; 33(4): 446.     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Phase III, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
    Linong Ji, Jianhua Ma, Weiping Lu, Jingdong Liu, Jiao’e Zeng, Jialin Yang, Wei Li, Xiuzhen Zhang, Xinhua Xiao, Gen Takayanagi, Yi Wang
    Journal of Diabetes Investigation.2021; 12(4): 537.     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Blood glucose levels and bodyweight change after dapagliflozin administration
    Hyunah Kim, Seung‐Hwan Lee, Hyunyong Lee, Hyeon Woo Yim, Jae‐Hyoung Cho, Kun‐Ho Yoon, Hun‐Sung Kim
    Journal of Diabetes Investigation.2021; 12(9): 1594.     CrossRef
  • Effects of liraglutide combined with metformin and Diamicron on glucose–lipid metabolism and islet β-cell function in elderly patients with type 2 diabetes mellitus
    Chunzhi Zhao, Xing Li, Jianhua Ma, Zhengtai Zhu, Hua Li, Fangli Lou, Yuefang Zhai, Hui Chen, Shujun Xiao, Qinhui Peng, Huilian Hua, Qing Zhang, Fangyong Lou
    All Life.2021; 14(1): 333.     CrossRef
  • Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial
    Ling Qu, Xiaochun Liang, Guoqing Tian, Gaili Zhang, Qunli Wu, Xiumei Huang, Yazhong Cui, Yuling Liu, Zhufang Shen, Changqing Xiao, Yingfen Qin, Heng Miao, Yongyan Zhang, Ziling Li, Shandong Ye, Xuezhi Zhang, Jing Yang, Guiwen Cao, Yi Li, Gangyi Yang, Ji H
    Diabetes Care.2021; 44(6): 1324.     CrossRef
  • Clinical Impact of Combination Therapy in Diabetic Neuropathy and Nephropathy
    Harmeet Kaur, Arvinder Kaur, Pankaj Kumar Prashar, Anamika Gautam, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar
    Research Journal of Pharmacy and Technology.2021; : 3471.     CrossRef
  • Effect of Voluntary Participation on Mobile Health Care in Diabetes Management: Randomized Controlled Open-Label Trial
    Da Young Lee, Seung-Hyun Yoo, Kyong Pil Min, Cheol-Young Park
    JMIR mHealth and uHealth.2020; 8(9): e19153.     CrossRef
  • Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
    Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
  • Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
    Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee, Young Sik Choi, Duk Kyu Kim, In Joo Kim
    Diabetes & Metabolism Journal.2020; 44(1): 67.     CrossRef
  • Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
    Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
    Jae Hyun Bae, Hyung Jin Choi, Kang Ik Kevin Cho, Lee Kyung Kim, Jun Soo Kwon, Young Min Cho
    Diabetes & Metabolism Journal.2020; 44(2): 248.     CrossRef
  • Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects


    Hyounggyoon Yoo, Yun Kim, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
    Drug Design, Development and Therapy.2020; Volume 14: 5179.     CrossRef
  • Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
    Yun Kyung Cho, Jiwoo Lee, Yu Mi Kang, Jee Hee Yoo, Joong-Yeol Park, Chang Hee Jung, Woo Je Lee, Tatsuo Shimosawa
    PLOS ONE.2019; 14(8): e0220667.     CrossRef
  • Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double‐blind, non‐inferiority trial
    Yonghyun Kim, Eun Seok Kang, Hak Chul Jang, Dong Jun Kim, Taekeun Oh, Eun Sook Kim, Nan‐Hee Kim, Kyung Mook Choi, Sung‐Rae Kim, JiYoung You, Se‐Jin Kim, Moon‐Kyu Lee
    Diabetes, Obesity and Metabolism.2019; 21(3): 631.     CrossRef
  • Pharmacotherapy of Diabetes Focused on Stroke
    Young-Sang Lyu, Jin-Hwa Kim, Sang-Yong Kim
    Journal of the Korean Neurological Association.2019; 37(3): 235.     CrossRef
  • Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
    Hannah Seok, Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
  • Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors
    Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung Mo Nam, Eun Seok Kang
    Diabetes Care.2019; 42(11): 2057.     CrossRef
  • Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
    Tae Jung Oh, Jae Myung Yu, Kyung Wan Min, Hyun Shik Son, Moon Kyu Lee, Kun Ho Yoon, Young Duk Song, Joong Yeol Park, In Kyung Jeong, Bong Soo Cha, Yong Seong Kim, Sei Hyun Baik, In Joo Kim, Doo Man Kim, Sung Rae Kim, Kwan Woo Lee, Jeong Hyung Park, In Kyu
    Diabetes & Metabolism Journal.2019; 43(3): 276.     CrossRef
  • 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
    Mee Kyoung Kim, Seung-Hyun Ko, Bo-Yeon Kim, Eun Seok Kang, Junghyun Noh, Soo-Kyung Kim, Seok-O Park, Kyu Yeon Hur, Suk Chon, Min Kyong Moon, Nan-Hee Kim, Sang Yong Kim, Sang Youl Rhee, Kang-Woo Lee, Jae Hyeon Kim, Eun-Jung Rhee, SungWan Chun, Sung Hoon Yu
    Diabetes & Metabolism Journal.2019; 43(4): 398.     CrossRef
  • Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration
    Hun-Sung Kim, Dai-Jin Kim, Kun-Ho Yoon
    Endocrinology and Metabolism.2019; 34(4): 349.     CrossRef
  • Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
    Sang Youl Rhee
    The Journal of Korean Diabetes.2018; 19(1): 15.     CrossRef
  • Glucose Control in Intensive Care Unit Patients: Recent Updates
    Sang Youl Rhee
    Journal of Neurocritical Care.2018; 11(2): 81.     CrossRef
  • Educational Strategies for Insulin Injection Therapy in Elderly Diabetic Patients
    Eun Chong Shin
    The Journal of Korean Diabetes.2018; 19(2): 101.     CrossRef
  • Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
    Hyun Jin Kim
    The Journal of Korean Diabetes.2018; 19(1): 35.     CrossRef
  • Fifty Years of Compassionate Care and Harmonious Collaboration of the Korean Diabetes Association: The 50th Anniversary of Korean Diabetes Association
    Jong Chul Won, Eun-Jung Rhee, Hyung Joon Yoo
    Diabetes & Metabolism Journal.2018; 42(6): 475.     CrossRef
  • Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
    Kyung‐Ah Han, Suk Chon, Choon Hee Chung, Soo Lim, Kwan‐Woo Lee, SeiHyun Baik, Chang Hee Jung, Dong‐Sun Kim, Kyong Soo Park, Kun‐Ho Yoon, In‐Kyu Lee, Bong‐Soo Cha, Taishi Sakatani, Sumi Park, Moon‐Kyu Lee
    Diabetes, Obesity and Metabolism.2018; 20(10): 2408.     CrossRef
  • Monotherapy in Patients with Type 2 Diabetes Mellitus
    Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
    Diabetes & Metabolism Journal.2017; 41(5): 349.     CrossRef
  • Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
    Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
    The Korean Journal of Internal Medicine.2017; 32(6): 967.     CrossRef
  • New anti-diabetic agents
    Doo-Man Kim
    Journal of the Korean Medical Association.2017; 60(12): 992.     CrossRef
  • Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
    Hyun Jin Kim, Seok O Park, Seung-Hyun Ko, Sang Youl Rhee, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Byung-Wan Lee, Jin Hwa Kim, Kyung Mook Choi
    Diabetes & Metabolism Journal.2017; 41(6): 423.     CrossRef
  • Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
    Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
    Diabetes & Metabolism Journal.2017; 41(5): 367.     CrossRef
Clinical Diabetes & Therapeutics
Monotherapy in Patients with Type 2 Diabetes Mellitus
Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
Diabetes Metab J. 2017;41(5):349-356.   Published online October 19, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.349
  • 5,646 View
  • 70 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   

In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glucose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.

Citations

Citations to this article as recorded by  
  • Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms
    Pranay Wal, Jyotsana Dwivedi, Ankita Wal, Shivangi Kushwaha
    Current Diabetes Reviews.2023;[Epub]     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors
    Amani Toumi, Sarra Boudriga, Khaled Hamden, Mansour Sobeh, Mohammed Cheurfa, Moheddine Askri, Michael Knorr, Carsten Strohmann, Lukas Brieger
    Bioorganic Chemistry.2021; 106: 104507.     CrossRef
  • Clinical Impact of Combination Therapy in Diabetic Neuropathy and Nephropathy
    Harmeet Kaur, Arvinder Kaur, Pankaj Kumar Prashar, Anamika Gautam, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar
    Research Journal of Pharmacy and Technology.2021; : 3471.     CrossRef
  • Type II diabetes mellitus: a review on recent drug based therapeutics
    Santwana Padhi, Amit Kumar Nayak, Anindita Behera
    Biomedicine & Pharmacotherapy.2020; 131: 110708.     CrossRef
  • Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)
    Soo Heon Kwak, You‐Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang‐Yong Kim, Jae Hyeon Kim
    Diabetes, Obesity and Metabolism.2020; 22(2): 173.     CrossRef
  • Metabolomics approach to identify the active substances influencing the antidiabetic activity of Lagerstroemia species
    Mun-Ock Kim, Su Ui Lee, Heung Joo Yuk, Hyun-Jae Jang, Jae-Won Lee, Eun-Bin Kwon, Jin-Hyub Paik, SangHo Choi, Adek Nizar, Tran The Bach, Kongmany Sydara, Hang Jin, So-Yeun Woo, Sei-Ryang Oh, Hyung Won Ryu
    Journal of Functional Foods.2020; 64: 103684.     CrossRef
  • Cardiometabolic diseases and active aging - polypharmacy in control
    Adriana Nancy Medeiros dos Santos, Dulcineia Rebecca Cappelletti Nogueira, Beatriz Aparecida Ozello Gutierrez, Rosa Yuka Sato Chubaci, Caroline Ribeiro de Borja Oliveira
    Revista Brasileira de Enfermagem.2020;[Epub]     CrossRef
  • Anti-Diabetic Nephropathy Activities of Polysaccharides Obtained from Termitornyces albuminosus via Regulation of NF-κB Signaling in db/db Mice
    Chang Yang, Qi Feng, Huan Liao, Xinlei Yu, Yang Liu, Di Wang
    International Journal of Molecular Sciences.2019; 20(20): 5205.     CrossRef
  • Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes
    Min Joo Kim, Mi Na Kim, Se Hee Min, Dong-Sik Ham, Ji-Won Kim, Kun-Ho Yoon, Kyong Soo Park, Hye Seung Jung
    Metabolism.2019; 97: 87.     CrossRef
  • A randomized, open‐label, multicentre, parallel‐controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti
    Lixin Guo, Li Chen, Baocheng Chang, Liyong Yang, Yu Liu, Bo Feng
    Diabetes, Obesity and Metabolism.2018; 20(12): 2740.     CrossRef
  • Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
    Sang Youl Rhee
    The Journal of Korean Diabetes.2018; 19(1): 15.     CrossRef
Clinical Diabetes & Therapeutics
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
Min Kyong Moon, Kyu-Yeon Hur, Seung-Hyun Ko, Seok-O Park, Byung-Wan Lee, Jin Hwa Kim, Sang Youl Rhee, Hyun Jin Kim, Kyung Mook Choi, Nan-Hee Kim
Diabetes Metab J. 2017;41(5):357-366.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.357
  • 7,617 View
  • 150 Download
  • 17 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   

The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic agents (OHAs), general recommendations were not changed from those of the 2015 KDA guidelines. The Committee on Clinical Practice Guidelines of the KDA has extensively reviewed and discussed the results of meta-analyses and systematic reviews of effectiveness and safety of OHAs and many clinical trials on Korean patients with T2DM for the update of guidelines. All OHAs were effective when added to metformin or metformin and sulfonylurea, although the effects of each agent on body weight and hypoglycemia were different. Therefore, selection of a second agent as a metformin add-on therapy or third agent as a metformin and sulfonylurea add-on therapy should be based on the patient's clinical characteristics and the efficacy, side effects, mechanism of action, risk of hypoglycemia, effect on body weight, patient preference, and combined comorbidity. In this review, we address the results of meta-analyses and systematic reviews, comparing the effectiveness and safety among OHAs. It will help to choose the appropriate drug for an individual patient with T2DM.

Citations

Citations to this article as recorded by  
  • Unveiling the potential of prodrug and drug-conjugate strategies in treatment of diabetes mellitus and its complications
    Neha V. Bhilare, Rushikesh Shedge, Prashant M. Tambe, Ajinkya More
    Medicinal Chemistry Research.2024; 33(3): 337.     CrossRef
  • Simultaneous Estimation of Repaglinide and Voglibose in Newly Approved Fixed-Dose Combination by using UFLC: Application to ICH Q14 Concept and Comparative Method Greenness Assessment
    S.S. Panda, P.C. Rauta, V.S. Pulusu, S. Sahu, B.B. Dash
    Asian Journal of Chemistry.2023; 35(4): 887.     CrossRef
  • Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
    Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
    International Journal of Diabetes in Developing Countries.2023; 43(6): 856.     CrossRef
  • The Gut Microbiome, Metformin, and Aging
    Sri Nitya Reddy Induri, Payalben Kansara, Scott C. Thomas, Fangxi Xu, Deepak Saxena, Xin Li
    Annual Review of Pharmacology and Toxicology.2022; 62(1): 85.     CrossRef
  • Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial
    Wajiha Mahjabeen, Dilshad Ahmed Khan, Shakil Ahmed Mirza
    Complementary Therapies in Medicine.2022; 66: 102819.     CrossRef
  • Letrozole: Pharmacology, toxicity and potential therapeutic effects
    Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Dhanushya Nagarajan, Vibhaa K K, Anagha V, Joshua Paul P, Tharani Priya T, Rituraj Chakraborty, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Abilash Valsala Gopalakrishnan
    Life Sciences.2022; 310: 121074.     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non‐interventional comparative study
    Sirajudeen Shaik Alavudeen, Sultan M. Alshahrani, Easwaran Vigneshwaran, Noohu Abdulla Khan, Javid I. Mir, Abubakr T. M. Hussein
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus
    Antonios Kousaxidis, Anthi Petrou, Vasiliki Lavrentaki, Maria Fesatidou, Ioannis Nicolaou, Athina Geronikaki
    European Journal of Medicinal Chemistry.2020; 207: 112742.     CrossRef
  • Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
    Hannah Seok, Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
  • A Survey of the Structures of US FDA Approved Combination Drugs
    Pradipta Das, Michael D. Delost, Munaum H. Qureshi, David T. Smith, Jon T. Njardarson
    Journal of Medicinal Chemistry.2019; 62(9): 4265.     CrossRef
  • Experimental design methodology for optimization and robustness determination in ion pair RP-HPLC method development: Application for the simultaneous determination of metformin hydrochloride, alogliptin benzoate and repaglinide in tablets
    Marianne A. Mahrouse, Nesrine T. Lamie
    Microchemical Journal.2019; 147: 691.     CrossRef
  • The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
    Da Young Lee, Ji Hee Yu, Sanghyun Park, Kyungdo Han, Nam Hoon Kim, Hye Jin Yoo, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim, Ji A. Seo
    Scientific Reports.2018;[Epub]     CrossRef
  • Effect of Lifestyle Modification and Oral Anti-Diabetic Drugs on Metabolic Parameters in Recently Diagnosed Patientswith Uncomplicated Type 2 Diabetes Mellitus in Eastern India
    Nikhilesh Pradhan, Sidhartha Das, Anoj Kumar Baliarsinha, Ashirbad Parhi, Bijan Patnaik, Pramod Kumar Rout
    Journal of Diabetes Mellitus.2018; 08(02): 9.     CrossRef
  • Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program
    Ja Young Jeon, Soo Jin Lee, Sieun Lee, Soo Jin Kim, Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Young Seol Kim, Jeong Taek Woo, Kyu Jeung Ahn, Moonsuk Nam, Sei Hyun Baik, Yongsoo Park, Kwan‐Woo Lee
    Journal of Diabetes Investigation.2018; 9(5): 1144.     CrossRef
Clinical Diabetes & Therapeutics
Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
Diabetes Metab J. 2017;41(5):367-373.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.367
  • 7,425 View
  • 220 Download
  • 7 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

Citations

Citations to this article as recorded by  
  • Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
    Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
    Advances in Therapy.2024;[Epub]     CrossRef
  • Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
    Youngsook Kim, Ji Hye Huh, Minyoung Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Effects of an actual insulin injection demonstration on insulin acceptance among patients with T2DM: a pragmatic randomized controlled trial
    Atthayaporn Choomai, Apichai Wattanapisit, Orathai Tiangtam
    Romanian Journal of Internal Medicine.2021; 59(2): 151.     CrossRef
  • Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
    Han Na Jang, Ye Seul Yang, Seong Ok Lee, Tae Jung Oh, Bo Kyung Koo, Hye Seung Jung
    Endocrinology and Metabolism.2019; 34(4): 382.     CrossRef
  • Capacity and confidence building for general practitioners on optimum insulin use
    Sanjay Kalra, Prasun Deb, KalyanK Gangopadhyay, Sunil Gupta, Abhay Ahluwalia
    Journal of Family Medicine and Primary Care.2019; 8(10): 3096.     CrossRef
  • Educational Strategies for Insulin Injection Therapy in Elderly Diabetic Patients
    Eun Chong Shin
    The Journal of Korean Diabetes.2018; 19(2): 101.     CrossRef
  • Summary of Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
    Byung-Wan Lee
    The Journal of Korean Diabetes.2018; 19(1): 31.     CrossRef
  • New anti-diabetic agents
    Doo-Man Kim
    Journal of the Korean Medical Association.2017; 60(12): 992.     CrossRef
Editorial
Clinical Diabetes & Therapeutics
Changes in the Bone Mineral Density of Femur Neck and Total Hip Over a 52-Week Treatment with Lobeglitazone
Da Young Lee, Ji A Seo
Diabetes Metab J. 2017;41(5):374-376.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.374
  • 3,057 View
  • 27 Download
PDFPubReader   
Original Articles
Clinical Diabetes & Therapeutics
Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
Soo Lim, Kyoung Min Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yongsoo Park, Sang Jin Kim, Hak Chul Jang, Dong Seop Choi
Diabetes Metab J. 2017;41(5):377-385.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.377
  • 4,260 View
  • 42 Download
  • 19 Web of Science
  • 20 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of this multicenter, randomized, double-blind study was to examine the effect of lobeglitazone, a novel thiazolidinedione, on the changes in bone mineral density (BMD) in patients with type 2 diabetes mellitus.

Methods

A 24-week, double-blinded phase was followed by a 28-week, open-label phase, in which the placebo group also started to receive lobeglitazone. A total of 170 patients aged 34 to 76 years were randomly assigned in a 2:1 ratio to receive lobeglitazone 0.5 mg or a matching placebo orally, once daily. BMD was assessed using dual-energy X-ray absorptiometry at week 24 and at the end of the study (week 52).

Results

During the double-blinded phase, the femur neck BMD showed decreasing patterns in both groups, without statistical significance (−0.85%±0.36% and −0.78%±0.46% in the lobeglitazone and placebo groups, respectively). The treatment difference between the groups was 0.07%, which was also not statistically significant. Further, minimal, nonsignificant decreases were observed in both groups in the total hip BMD compared to values at baseline, and these differences also did not significantly differ between the groups. During the open-label phase, the BMD was further decreased, but not significantly, by −0.32% at the femur neck and by −0.60% at the total hip in the lobeglitazone group, and these changes did not significantly differ compared with the original placebo group switched to lobeglitazone.

Conclusion

Our results indicate that treatment with lobeglitazone 0.5 mg over 52 weeks showed no detrimental effect on the BMD compared to the placebo.

Citations

Citations to this article as recorded by  
  • Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis
    Deep Dutta, Saptarshi Bhattacharya, Manoj Kumar, Priyankar K. Datta, Ritin Mohindra, Meha Sharma
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(1): 102697.     CrossRef
  • Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis
    Shashank R. Joshi, Saibal Das, Suja Xaviar, Shambo Samrat Samajdar, Indranil Saha, Sougata Sarkar, Shatavisa Mukherjee, Santanu Kumar Tripathi, Jyotirmoy Pal, Nandini Chatterjee
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(1): 102703.     CrossRef
  • The benefits of adipocyte metabolism in bone health and regeneration
    Lisa-Marie Burkhardt, Christian H. Bucher, Julia Löffler, Charlotte Rinne, Georg N. Duda, Sven Geissler, Tim J. Schulz, Katharina Schmidt-Bleek
    Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
  • Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal
    Kalyan Kumar Gangopadhyay, Awadhesh Kumar Singh
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(4): 102747.     CrossRef
  • Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study
    Jun Hwa Hong, Jun Sung Moon, Kayeon Seong, Soo Lim
    Diabetes Research and Clinical Practice.2023; 203: 110872.     CrossRef
  • Bone Mineral Density Evaluation Among Type 2 Diabetic Patients in Rural Haryana, India: An Analytical Cross-Sectional Study
    Nitish Khandelwal, Surbhi Rajauria, Siddhesh Pandurang Kanjalkar, Omkar Shivaji Chavanke, Sanjay Rai
    Cureus.2023;[Epub]     CrossRef
  • Lobeglitazone and Its Therapeutic Benefits: A Review
    Balamurugan M, Sarumathy S, Robinson R
    Cureus.2023;[Epub]     CrossRef
  • A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
    Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
    Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef
  • A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
    Bo-Yeon Kim, Hyuk-Sang Kwon, Suk Kyeong Kim, Jung-Hyun Noh, Cheol-Young Park, Hyeong-Kyu Park, Kee-Ho Song, Jong Chul Won, Jae Myung Yu, Mi Young Lee, Jae Hyuk Lee, Soo Lim, Sung Wan Chun, In-Kyung Jeong, Choon Hee Chung, Seung Jin Han, Hee-Seok Kim, Ju-Y
    Diabetes & Metabolism Journal.2022; 46(6): 855.     CrossRef
  • Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
    Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
    Diabetes Therapy.2021; 12(1): 171.     CrossRef
  • Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
    Jaehyun Bae, Taegyun Park, Hyeyoung Kim, Minyoung Lee, Bong-Soo Cha
    Diabetes & Metabolism Journal.2021; 45(3): 326.     CrossRef
  • Effect of lobeglitazone on motor function in rat model of Parkinson’s disease with diabetes co-morbidity
    Kambiz Hassanzadeh, Arman Rahimmi, Mohammad Raman Moloudi, Rita Maccarone, Massimo Corbo, Esmael Izadpanah, Marco Feligioni
    Brain Research Bulletin.2021; 173: 184.     CrossRef
  • Recent Perspective on Thiazolidinedione
    Won Jun Kim
    The Journal of Korean Diabetes.2021; 22(2): 97.     CrossRef
  • Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models
    Sabrina Ehnert, Helen Rinderknecht, Romina H. Aspera-Werz, Victor Häussling, Andreas K. Nussler
    Archives of Toxicology.2020; 94(12): 3937.     CrossRef
  • Update on: effects of anti-diabetic drugs on bone metabolism
    Guillaume Mabilleau, Béatrice Bouvard
    Expert Review of Endocrinology & Metabolism.2020; 15(6): 415.     CrossRef
  • The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta‐analysis of observational studies
    Khemayanto Hidayat, Xuan Du, Meng‐Jiao Wu, Bi‐Min Shi
    Obesity Reviews.2019; 20(10): 1494.     CrossRef
  • Diabetes pharmacotherapy and effects on the musculoskeletal system
    Evangelia Kalaitzoglou, John L. Fowlkes, Iuliana Popescu, Kathryn M. Thrailkill
    Diabetes/Metabolism Research and Reviews.2019;[Epub]     CrossRef
  • Morin Exerts Anti‐Arthritic Effects by Attenuating Synovial Angiogenesis via Activation of Peroxisome Proliferator Activated Receptor‐γ
    Mengfan Yue, Ni Zeng, Yufeng Xia, Zhifeng Wei, Yue Dai
    Molecular Nutrition & Food Research.2018;[Epub]     CrossRef
  • The effects of diabetes therapy on bone: A clinical perspective
    Karim G. Kheniser, Carmen M. Polanco Santos, Sangeeta R. Kashyap
    Journal of Diabetes and its Complications.2018; 32(7): 713.     CrossRef
  • Changes in the Bone Mineral Density of Femur Neck and Total Hip Over a 52-Week Treatment with Lobeglitazone
    Da Young Lee, Ji A Seo
    Diabetes & Metabolism Journal.2017; 41(5): 374.     CrossRef
Epidemiology
Performance of the Achutha Menon Centre Diabetes Risk Score in Identifying Prevalent Diabetes in Tamil Nadu, India
Anu Mary Oommen, Vinod Joseph Abraham, Thirunavukkarasu Sathish, V. Jacob Jose, Kuryan George
Diabetes Metab J. 2017;41(5):386-392.   Published online August 25, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.386
  • 2,896 View
  • 33 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   
Background

The Achutha Menon Centre Diabetes Risk Score (AMCDRS), which was developed in rural Kerala State, South India, had not previously been externally validated. We examined the performance of the AMCDRS in urban and rural areas in the district of Vellore in the South Indian state of Tamil Nadu, and compared it with other diabetes risk scores developed from India.

Methods

We used the data from 4,896 participants (30 to 64 years) of a cross-sectional study conducted in Vellore (2010 to 2012), to calculate the AMCDRS scores using age, family history, and waist circumference. Sensitivity, specificity, positive predictive value (PPV), and negative predictive values (NPV), and the area under the receiver operating characteristic curve (AROC) were calculated for undiagnosed and total diabetes.

Results

Of the 4,896 individuals surveyed, 274 (5.6%) had undiagnosed diabetes and 759 (15.5%) had total diabetes. The AMCDRS, with an optimum cut-point of ≥4, identified 45.0% for further testing with 59.5% sensitivity, 60.5% specificity, 9.1% PPV, 95.8% NPV, and an AROC of 0.639 (95% confidence interval [CI], 0.608 to 0.670) for undiagnosed diabetes. The corresponding figures for total diabetes were 75.1%, 60.5%, 25.9%, 93.0%, and 0.731 (95% CI, 0.713 to 0.750), respectively. The AROC for the AMCDRS was not significantly different from that of the Indian Diabetes Risk Score, the Ramachandran or the Chaturvedi risk scores for total diabetes, but was significantly lower than the AROC of the Chaturvedi score for undiagnosed diabetes.

Conclusion

The AMCDRS is a simple diabetes risk score that can be used to screen for undiagnosed and total diabetes in low-resource primary care settings in India. However, it probably requires recalibration to improve its performance for undiagnosed diabetes.

Citations

Citations to this article as recorded by  
  • Evaluating the Performance of the Indian Diabetes Risk Score in Different Ethnic Groups
    Manjula D. Nugawela, Sobha Sivaprasad, Viswanathan Mohan, Ramachandran Rajalakshmi, Gopalakrishnan Netuveli
    Diabetes Technology & Therapeutics.2020; 22(4): 285.     CrossRef
  • Targeted screening for prediabetes and undiagnosed diabetes in a community setting in India
    Thirunavukkarasu Sathish, Jonathan E. Shaw, Robyn J. Tapp, Rory Wolfe, Kavumpurathu R. Thankappan, Sajitha Balachandran, Brian Oldenburg
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 1785.     CrossRef
  • OBSERVATIONAL STUDY EVALUATING ASSOCIATION OF TYPE 2 DIABETES MELLITUS AND THYROID DYSFUNCTION
    Elizabeth Jacob, Vivek Koshy Varghese, Tittu Oommen
    Journal of Evidence Based Medicine and Healthcare.2018; 5(31): 2285.     CrossRef
Complications
Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data
Sejeong Park, Sang Youl Rhee, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo
Diabetes Metab J. 2017;41(5):393-404.   Published online September 5, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.393
  • 5,083 View
  • 44 Download
  • 16 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   
Background

This is part of a prospective study carried out as a national project to secure standardized public resources for type 2 diabetes mellitus (T2DM) patients in Korea. We compared various characteristics of long-standing T2DM patients with diabetic retinopathy (DR) and macular edema (ME).

Methods

From September 2014 to July 2015, T2DM patients with disease duration of at least 15 years were recruited at a single university hospital. Clinical data and samples were collected according to the common data elements and standards of procedure developed by the Korean Diabetes Association Research Council. Each participant was assessed by ophthalmologists for DR and ME.

Results

Among 220 registered patients, 183 completed the ophthalmologic assessment. DR was associated with longer disease duration (odds ratio [OR], 1.071; 95% confidence interval [CI], 1.001 to 1.147 for non-proliferative diabetic retinopathy [NPDR]) (OR, 1.142; 95% CI, 1.051 to 1.242 for proliferative diabetic retinopathy [PDR]) and the use of long-acting insulin (OR, 4.559; 95% CI, 1.672 to 12.427 for NPDR) (OR, 4.783; 95% CI, 1.581 to 14.474 for PDR), but a lower prevalence of a family history of cancer (OR, 0.310; 95% CI, 0.119 to 0.809 for NPDR) (OR, 0.206; 95% CI, 0.063 to 0.673 for PDR). ME was associated with higher glycosylated hemoglobin levels (OR, 1.380; 95% CI, 1.032 to 1.845) and the use of rapid-acting insulin (OR, 5.211; 95% CI, 1.445 to 18.794).

Conclusion

Various clinical features were associated with DR and ME. Additional epidemiological and biorepository-based studies using this cohort are being conducted to deepen our understanding of diabetic complications in Korea.

Citations

Citations to this article as recorded by  
  • Diabetic retinopathy related homeostatic dysregulation and its association with mortality among diabetes patients: A cohort study from NHANES
    Wenxiang Li, Zhaoguang Lai, Ningning Tang, Fen Tang, Guangyi Huang, Peng Lu, Li Jiang, Daizai Lei, Fan Xu
    Diabetes Research and Clinical Practice.2024; 207: 111081.     CrossRef
  • Study on the Interaction Between C3 Gene Polymorphism and Environment in Patients with Type 2 Diabetes Combined with Coronary Artery Disease
    Haitang Qiu, Shajidan Abudureyimu, Mengjia Liu, Fen Liu, Ying Gao
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1467.     CrossRef
  • Cluster analysis of patient characteristics, treatment modalities, renal impairments, and inflammatory markers in diabetes mellitus
    Milena Cojic, Aleksandra Klisic, Amina Sahmanovic, Nemanja Petrovic, Gordana Kocic
    Scientific Reports.2024;[Epub]     CrossRef
  • Amino acid analysis as a method of discovering biomarkers for diagnosis of diabetes and its complications
    Dan Cai, Biao Hou, Song Lin Xie
    Amino Acids.2023; 55(5): 563.     CrossRef
  • The correlation between peripheral complete blood count parameters and diabetic macular edema in proliferative diabetic retinopathy patients: a cross-sectional study
    Chunyan Lei, Jinyue Gu, Lili Liu, Keren Zhang, Meixia Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy
    Chunyan Lei, Yun Zhang, Meixia Zhang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema
    Sang Youl Rhee, Eun Sung Jung, Dong Ho Suh, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo, Choong Hwan Lee
    Scientific Reports.2021;[Epub]     CrossRef
  • SYSTEMIC FACTORS AND EARLY TREATMENT RESPONSE TO INTRAVITREAL INJECTION FOR DIABETIC MACULAR EDEMA
    Hyeseong Hwang, Hwanho Lee, Jin Young Kim, Suhwan Lee, Eoi Jong Seo, Ju Byung Chae, Dong Yoon Kim
    Retina.2021; 41(6): 1275.     CrossRef
  • Relationship between Clinical Features of Diabetic Retinopathy and Systemic Factors in Patients with Newly Diagnosed Type II Diabetes Mellitus
    Hyeseong Hwang, Jin Young Kim, Tae Keun Oh, Ju Byung Chae, Dong Yoon Kim
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
    Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
    Jun Sung Moon
    Diabetes & Metabolism Journal.2019; 43(6): 911.     CrossRef
  • Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study
    Marta Ondrejkova, Peter Jackuliak, Emil Martinka, Marian Mokan, James Foley, Jana Fabkova, Karol Gecik, Iveta Tvrda, Miroslav Helbich, Monika Gajdosova, Tomislav Bulum
    PLOS ONE.2019; 14(12): e0223788.     CrossRef
  • Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis
    Seung-Hyun Ko, Kyungdo Han, Yong-ho Lee, Junghyun Noh, Cheol-Young Park, Dae-Jung Kim, Chang Hee Jung, Ki-Up Lee, Kyung-Soo Ko
    Diabetes & Metabolism Journal.2018; 42(2): 93.     CrossRef
  • Letter: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404)
    Jae-Seung Yun
    Diabetes & Metabolism Journal.2017; 41(6): 492.     CrossRef
  • Response: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404)
    Sang Youl Rhee, Jeong-Taek Woo
    Diabetes & Metabolism Journal.2017; 41(6): 494.     CrossRef
Others
Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD
So-Hyun Lee, Marie Rhee, Ji-Won Kim, Kun-Ho Yoon
Diabetes Metab J. 2017;41(5):405-416.   Published online September 5, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.405
  • 5,106 View
  • 64 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   
Background

To develop surrogate insulin-producing cells for diabetes therapy, adult stem cells have been identified in various tissues and studied for their conversion into β-cells. Pancreatic progenitor cells are derived from the endodermal epithelium and formed in a manner similar to gut progenitor cells. Here, we generated insulin-producing cells from the intestinal epithelial cells that induced many of the specific pancreatic transcription factors using adenoviral vectors carrying three genes: PMB (pancreatic and duodenal homeobox 1 [Pdx1], V-maf musculoaponeurotic fibrosarcoma oncogene homolog A [MafA], and BETA2/NeuroD).

Methods

By direct injection into the intestine through the cranial mesenteric artery, adenoviruses (Ad) were successfully delivered to the entire intestine. After virus injection, we could confirm that the small intestine of the mouse was appropriately infected with the Ad-Pdx1 and triple Ad-PMB.

Results

Four weeks after the injection, insulin mRNA was expressed in the small intestine, and the insulin gene expression was induced in Ad-Pdx1 and Ad-PMB compared to control Ad-green fluorescent protein. In addition, the conversion of intestinal cells into insulin-expressing cells was detected in parts of the crypts and villi located in the small intestine.

Conclusion

These data indicated that PMB facilitate the differentiation of mouse intestinal cells into insulin-expressing cells. In conclusion, the small intestine is an accessible and abundant source of surrogate insulin-producing cells.

Citations

Citations to this article as recorded by  
  • Harnessing gut cells for functional insulin production: Strategies and challenges
    Kelvin Baafi, John C. March
    Biotechnology Notes.2023; 4: 7.     CrossRef
  • Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children
    Lubov Borisovna Mitrofanova, Anastasia Arkadyevna Perminova, Daria Viktorovna Ryzhkova, Anna Andreyevna Sukhotskaya, Vladimir Gireyevich Bairov, Irina Leorovna Nikitina
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control
    Min Jung Kim, Eun Young Lee, Young-Hye You, Hae Kyung Yang, Kun-Ho Yoon, Ji-Won Kim
    Stem Cell Research.2020; 48: 101958.     CrossRef
  • ERK Regulates NeuroD1-mediated Neurite Outgrowth via Proteasomal Degradation
    Tae-young Lee, In-Su Cho, Narayan Bashyal, Francisco J Naya, Ming-Jer Tsai, Jeong Seon Yoon, Jung-Mi Choi, Chang-Hwan Park, Sung-Soo Kim, Haeyoung Suh-Kim
    Experimental Neurobiology.2020; 29(3): 189.     CrossRef
  • Generation of a PDX1–EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system
    Youngsun Lee, Hye Young Choi, Ara Kwon, Hyeyeon Park, Mi-Hyun Park, Ji-Won Kim, Min Jung Kim, Yong-Ou Kim, Sungwook Kwak, Soo Kyung Koo
    Stem Cell Research.2019; 41: 101632.     CrossRef
Letter
Letter: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J 2017;41:275-83)
Jeongmin Lee, Jae Hyoung Cho
Diabetes Metab J. 2017;41(5):417-419.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.417
  • 3,058 View
  • 32 Download
  • 2 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose–response meta-analysis of randomized trials
    Aliyu Tijani Jibril, Ahmad Jayedi, Sakineh Shab-Bidar
    Endocrine Connections.2022;[Epub]     CrossRef
  • Long-Term Sleep Deprivation-Induced Myocardial Remodeling and Mitochondrial Dysfunction in Mice Were Attenuated by Lipoic Acid and N-Acetylcysteine
    Fei Song, Jiale Lin, Houjian Zhang, Yuli Guo, Yijie Mao, Zuguo Liu, Gang Li, Yan Wang
    Pharmaceuticals.2022; 16(1): 51.     CrossRef
Response
Response: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J 2017;41:275-83)
Chong Hwa Kim, Sol Jae Lee, Bong Yun Cha
Diabetes Metab J. 2017;41(5):420-421.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.420
  • 3,642 View
  • 31 Download
  • 2 Web of Science
PDFPubReader   
Corrigendum
Corrigendum: Author's Name and Affiliation Correction. The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women
Zeinab AminiLari, Mohammad Fararouei, Sasan Amanat, Ehsan Sinaei, Aria Dianatinasab, Mahmood AminiLari, Nima Daneshi, Mostafa Dianatinasab
Diabetes Metab J. 2017;41(5):422-422.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.422
  • 2,935 View
  • 31 Download
  • 2 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Exploring the Impact of Combined Thai Yoga and Elastic Band Exercise on Physical Fitness and Exercise Capacity in Older Patients with Type 2 Diabetes
    Nattha Muangritdech, Tichanon Promsrisuk, Ratchaniporn Kongsui, Napatr Sriraksa, Sitthisak Thongrong, Arunrat Srithawong
    Physical Education Theory and Methodology.2023; 23(6): 894.     CrossRef
  • Effectiveness of Physical Therapy in Middle-Aged Women with Alimentary Form of Obesity of the First Degree
    Nataliia O. Vasylieva, Tetyana Koziy, Oksana Lavrykova, Yulia Karpukhina, Tetiana Biriukova
    Acta Balneologica.2022; 64(3): 230.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal